Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Equity Ratio (2024 - 2025)

Allarity Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.54 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 3.23% year-over-year to 0.54; the TTM value through Dec 2025 reached 0.54, up 3.23%, while the annual FY2025 figure was 0.54, 3.23% up from the prior year.
  • Equity Ratio reached 0.54 in Q4 2025 per ALLR's latest filing, down from 0.58 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.64 in Q2 2024 to a low of 0.54 in Q1 2024.